Rapid deterioration in a patient with primary aggressive cutaneous epidermotropic CD8+ cytotoxic T-cell ('Berti') lymphoma after administration of adalimumab.

Subjects

Subjects :

Adalimumab
Adult
Fatal Outcome
Female
Humans
Lymphoma, T-Cell, Cutaneous immunology
Lymphoma, T-Cell, Cutaneous pathology
Psoriasis diagnosis
Psoriasis drug therapy
Skin Neoplasms immunology
Skin Neoplasms pathology
Anti-Inflammatory Agents adverse effects
Antibodies, Monoclonal, Humanized adverse effects
Lymphoma, T-Cell, Cutaneous diagnosis
Skin Neoplasms diagnosis
T-Lymphocytes, Cytotoxic immunology

Details

Language :

English

ISSN :

1097-6787

Volume :

71

Issue :

3

Database :

MEDLINE

Journal :

Journal of the American Academy of Dermatology

Publication Type :

Report

Accession number :

25128139

Full Text :

https://doi.org/10.1016/j.jaad.2014.03.022